4.1 Therapeutic indication
Defitelio is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as
sinusoidal obstruction syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy.
It is indicated in adults and in adolescents, children and infants over 1 month of age